Kurdistan Board for Medical Specialist   Report issue

Academic/Hospital Phase 1
Founded: Erbil Iraq (2001)

Organization Overview

First Clinical Trial
2015
NCT03601338
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Kurdistan Board for Medical Specialist

Active Ingredients

Drugs in Phase 1 Trials (1)

bemiparin (Ivor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stillbirth (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1